ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CytomX, Amgen Decision Follows January
Generics BulletinApotex has further diversified its offerings by acquiring CanPrev, a Canadian provider of vitamins, supplements, and other natural health products, in a deal that the firm says introduces it into the
Generics BulletinThe US government was favored by a federal court in Washington D.C., after being sued by Vanda Pharmaceuticals for allegedly improperly disclosing the originator’s trade secrets and confidential comme
Pink SheetA federal court ruled in favor of the government after Vanda Pharmaceuticals alleged improper disclosure of trade secrets, as well as confidential commercial and proprietary information, to generics